Acupuncture and Gabapentin for Hot Flashes Among Breast Cancer Survivors

Status: Completed
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

Objectives: The overarching goal is to compare the effectiveness of acupuncture and gabapentin to their respective placebo controls in the treatment of hot flashes in breast cancer patients. The investigators primary specific aim will focus on determining the magnitude of response to placebo acupuncture versus placebo pills on hot flashes (HFs).

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: No
View:

• Women 18 years or older with a history of Stage I, II or III breast cancer for at least 12 months.

• Have been seen by an oncologist within the previous 6-month period and determined to be free of disease by clinical examination and history;

• Experienced at least two hot flashes daily over the seven-day screening period as based on the Daily Hot Flash Diary.

• Hot flashes have been present for at least a month before study entry.

• Willing to use non-hormonal contraceptives during the duration of the study if patient is premenopausal.

Locations
United States
Pennsylvania
Abramson Cancer Center of the Unviersity of Pennsylvania
Philadelphia
Time Frame
Start Date: January 2009
Completion Date: January 31, 2014
Participants
Target number of participants: 120
Treatments
Experimental: placebo pill
Experimental: placebo accupuncture
Experimental: accupuncture
Experimental: gabapentin
Authors
Related Therapeutic Areas
Sponsors
Leads: Abramson Cancer Center of the University of Pennsylvania

This content was sourced from clinicaltrials.gov

Similar Clinical Trials